Trial Profile
Phase III trial of ELND 005 in patients with Alzheimer's disease.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 06 Jul 2011
Price :
$35
*
At a glance
- Drugs ELND 005 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 10 May 2011 This trial is still in the planning stages.
- 11 Aug 2010 New trial record